Androgens in the etiology of Alzheimer's disease in aging men and possible therapeutic interventions

Journal of Alzheimer's Disease

Volumn 12, Issue 2, 2007, Pages 129-142

  Fuller, Stephanie J ^a,b   Tan, Robert S ^c   Martins, Ralph N ^a,b  

^a EDITH COWAN UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Androgen receptor; Andropause; Cognition; Dehydroepiandrosterone; Gonadotropin; Leuprolin; Testosterone

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANDROGEN; ANDROGEN RECEPTOR; ANDROGEN RECEPTOR AGONIST; ANDROSTANOLONE; APOLIPOPROTEIN E; AROMATASE INHIBITOR; ESTRADIOL; FLUTAMIDE; FOLLITROPIN; GLUCOSE; GONADOTROPIN ANTAGONIST; HORMONE RECEPTOR STIMULATING AGENT; LEUPRORELIN; LUTEINIZING HORMONE; PRASTERONE; PRASTERONE SULFATE; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE; TRESTOLONE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; ALZHEIMER DISEASE; ANDROPAUSE; BRAIN REGION; COGNITION; DEPTH PERCEPTION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; FOLLITROPIN BLOOD LEVEL; GLUCOSE METABOLISM; GONADOTROPIN BLOOD LEVEL; HIPPOCAMPUS; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; INNATE IMMUNITY; LUTEINIZING HORMONE BLOOD LEVEL; MEMORY DISORDER; MULTIINFARCT DEMENTIA; NERVE FIBER GROWTH; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN METABOLISM; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TASK PERFORMANCE; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 34848881672     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2007-12202     Document Type: Review

References (137)

1. E. Ahlbom, G.S. Prins and S. Ceccatelli, Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism, Brain Res 892 (2001), 255-262.
2. T. Azuma, Y. Nagai, T. Saito, M. Funauchi, T. Matsubara and S. Sakoda, The effect of dehydroepiandrosterone sulfate administration to patients with multi-infarct dementia, J Neurol Sci 162 (1999), 69-73.
3. M.J. Bain, B.L. Hart, K.D. Cliff and W.W. Ruehl, Predicting behavioral changes associated with age-related cognitive impairment in dogs, J Am Vet Med Assoc 218 (2001), 1792-1795.
4. A.M. Barron, S.J. Fuller, G. Verdile and R.N. Martins, Reproductive hormones modulate oxidative stress in Alzheimer's disease, Antioxid. Redox Signal 8 (2006), 2047-2059.
5. S. Bastianetto, C. Ramassamy, J. Poirier and R. Quirion, Dehydroepiandrosterone (DHEA) protects hipppocampal cells from oxidative stress-induced damage, Brain Res Mol Brain Res 66 (1999), 35-41.
6. S. Beyenberg, M. Watzka, H. Clusmann, I. Blumcke, F. Bidlingmaier, C.E. Elger and B. Stoffel-Wagner, Androgen receptor mRNA expression in the human hippocampus, Neurosci Lett 294 (2000), 25-28.
7. R.L. Bowen, M.A. Smith, P.L. Harris, Z. Kubat, R.N. Martins, R.J. Castellani, G. Perry and C.S. Atwood, Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology, J Neurosci Res 70 (2002), 514-518.
8. R.L. Bowen, G. Verdile, T. Liu, A.F. Parlow, G. Perry, M.A. Smith, R.N. Martins and C.S. Atwood, Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition, J Biol Chem 279 (2004), 20539-20545.
9. R.D. Brinton, Impact of estrogen therapy on Alzheimer's disease: a fork in the road? CNS Drugs 18 (2004), 405-422.
10. M.S. Burkhardt, J.K. Foster, R.M. Clarnette, S.A. Chubb, D.G. Bruce, P.D. Drummond, R.N. Martins and B.B. Yeap, Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men, J Clin Endocrinol Metab 91 (2006), 1168-1172.
11. L.E. Carlson, B.B. Sherwin and H.M. Chertkow, Relationships between dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels and everyday memory in Alzheimer's disease patients compared to healthy controls, Horm Behav 35 (1999), 254-263.
12. G. Casadesus, M.R. Garrett, K.M. Webber, A.W. Hartzler, C.S. Atwood, G. Perry, R.L. Bowen and M.A. Smith, The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease, Drugs RD 7 (2006), 187-193.
13. G. Casadesus, K.M. Webber, C.S. Atwood, M.A. Pappolla, G. Perry, R.L. Bowen and M.A. Smith, Luteinizing hormone modulates cognition and amyloid-beta deposition in Alzheimer APP transgenic mice, Biochem Biophys Acta 1762 (2006), 447-452.
14. I. Charalampopoulos, V.I. Alexaki, I. Lazaridis, E. Dermitzaki, N. Avlonitis, C. Tsatsanis, T. Calogeropoulou, A.N. Margioris, E. Castanas and A. Gravanis, G-protein-associated specific binding sites mediate the neuroprotective effect of dehydroepiandrosterone, FASEB J 20 (2006), 577-579.
15. F. Chen, G.A. Rodan and A. Schmidt, Development of selective androgen receptor modulators and their therapeutic applications, Zhonghya Nan Ke Xue 8 (2002), 162-168.
16. M.M. Cherrier, S. Asthana, S. Plymate, L. Baker, A.M. Matsumoto, E. Peskind M.A. Raskind, K. Brodkin, W. Bremner, A. Petrova, S. LaTendressi and S. Craft, Testosterone supplementation improves spatial and verbal memory in healthy older men, Neurology 57 (2001), 80-88.
17. M.M. Cherrier, A.M. Matsumoto, J.K. Amory, S. Ahmed, W. Bremner, E.R. Peskind, M.A. Raskind, M. Johnson and S. Craft, The role of aromatization in testosterone supplementation, Neurology 64 (2005), 290-296.
18. C.A. Colton, C.M. Brown and M.P. Vitek, Sex steroids, APOE genotype and the innate immune system, Neurobiol Aging 26 (2005), 363-372.
19. O. Combarros, J.A. Riancho, J. Infante, C. Sanudo, J. Llorca, M.T. Zarrabeitia and J. Berciano, Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk, Dement Geriatr Cogn Disord 20 (2005), 153-157.
20. H.D. Danenberg, R. Haring and A. Fisher, Dehydroepiandrosterone(DHEA) increases production and release of Alzheimer's amyloid precursor protein, Life Sci 59 (1996), 1651-1657.
21. H.D. Danenberg, R. Haring, E. Heldman, D. Gurwitz, D. Ben-Nathan, Z. Pittel, A. Zuckerman and A. Fisher, Dehydroepiandrosterone augments M1-muscarinic receptor-stimulated amyloid precursor protein secretion in desensitized PC12M1 cells, Ann NY Acad Sci 774 (1995), 300-303.
22. J. R. Day, A. T. Frank, J.P. O'Callaghan, B.C. Jones and J. E. Anderson, The effect of age and testosterone on the expression of glial fibrillary acidic protein in the rat cerebellum, Exp Neurol 151 (1998), 343-346.
23. S.D. Edland, W.A. Rocca, R.C. Petersen, R.H. Cha and E. Kokmen, Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn Arch Neurol 59 (2002), 1589-1593.
24. R. Egensperger, S. Kosel, U. von Eitzen and M.B. Graeber, Microglial activation in Alzheimer disease: Association with APOE genotype, Brain Pathol 8 (1998), 439-447.
25. K.M. English, O. Mandour, R.P. Steeds, M.J. Diver, T.H. Jones and K.S. Channer, Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms, Eur Heart J 21 (2000), 890-894.
26. D. Eser, C. Schule, T.C. Baghai, E. Romeo, D.P. Uzunov and R. Rupprecht, Neuroactive steroids and affective disorders, Pharmacol Biochem Behav 84 (2006), 656-666.
27. C.G. Evans, S. Wisen and J.E. Gestwicki, Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro, J Biol Chem 281 (2006), 33182-33191.
28. J.F. Flood, S.A. Farr, F.E. Kaiser, M. La Regina and J.E. Morley, Age-related decrease of plasma testosterone in SAMP8 mice: Replacement improves age-related impairment of learning and memory, Physiol Behav 57 (1995), 669-673.
29. J.E. Flood and E. Roberts, Dehydroepiandrosterone sulfate improves memory in aging mice, Brain Res 448 (1988), 178-181.
30. C.A. Frye and E.H. Lacey, The neurosteroids DHEA and DHEAS may influence cognitive performance by altering affective state, Physiol Behav 66 (1999), 85-92.
31. C.A. Frye and A.M. Seliga, Testosterone increases analgesia, anxiolysis, and cognitive performance of male rats, Cogn Affect Behav Neurosci 1 (2001), 371-381.
32. S. Gandy, O.P. Almeida, J. Fonte, D. Lim, A. Waterrus, N. Spry, L. Flicker and R.N. Martins, Chemical andropause and amyloid-β peptide, JAMA 285 (2001), 2195-2196.
33. M.I. Geerlings, D. Strozyk, K. Masaki, A.T. Remaley, H. Petrovitch, G.W. Ross, L.R. White and L.J. Launer, Endogenous sex hormones, cognitive decline, and future dementia in old men, Ann Neurol 60 (2006), 346-355.
34. A.R. Genazzani and M. Gambacciani, Hormone replacement therapy: the perspectives for the 21st century, Maturitas 32 (1999), 11-17.
35. S. Goodenough, S. Engert and C. Behl, Testosterone stimulates rapid secretory amyloid precursor protein from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway, Neurosci Lett 296 (2000), 49-52.
36. G.K. Gouras, H. Xu, R.S. Gross, J.P. Greenfield, B. Hai, R. Wang and P. Greengard, Testosterone reduces neuronal secretion of Alzheimer's β-amyloid peptides, Proc Natl Acad Sci 97 (2000), 1202-1205.
37. D. Grady, K. Yaffe, M. Kristof, F. Liu, C. Richards and E. Barrett-Connor, Effect of postmenopausal therapy on cognitive function: the Heart & Estrogen/Progestin Replacement Study, Am J Med 113 (2002), 543-548.
38. A.T. Guay, S. Bansal and G.J. Heatley, Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: double blind placebo-controlled trial with clomiphene citrate, J Clin Endocrinol Metab 80 (1995), 3546-3552.
39. R.J. Haier, B.V. Siegel Jr, A. MacLachlan, E. Soderling, S. Lottenberg and M.S. Buchsbaum, Regional glucose metabolic changes after learning a complex visuospatial/motor task: a positron emission tomographic study, Brain Res 570 (1992), 134-143.
40. M.T. Haren, J.E. Morley, I.M. Chapman and P.D. O'Loughlin, Defining 'relative' androgen deficiency in aging men: how should testosterone be measured and what are the relationships between androgen levels and physical, sexual and emotional health? Climacteric 5 (2002), 15-25.
41. B.L. Hart, Effect of gonadectomy on subsequent development of age-related cognitive impairment in dogs, J Am Vet Med Assoc 219 (2001), 51-56.
42. J.G. Herndon, A. Lacreuse, E. Ladinsky, R.J. Killiany, D.L. Rosene and M.B. Moss, Age-related decline in DHEAS is not related to cognitive impairment in aged monkeys, Neuroreport 10 (1999), 3507-3511.
43. E. Hogervorst, S. Bandelow, M. Combrinck and A.D. Smith, Low free testosterone is an independent risk factor for Alzheimer's disease, Exp Gerontol 39 (2004), 1633-1639.
44. E. Hogervorst, D.J. Lehmann, D.R. Warden, J. McBroom and A.D. Smith, Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men, Int J Geriatr Psychiatry 17 (2002), 938-940.
45. R. Huang and S.E. Podluso, CYP19 haplotypes increase risk for Alzheimer's disease, J Med Genet 43 (2006), e42.
46. S. Iivonen, E. Corder, M. Lehtovirta, S. Helisalmi, A. Mannermaa, S. Vepsalainen, T. Hanninen, H. Soininen and M. Hiltunen, Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease, Neurology 62 (2004), 1170-1176.
47. T.A. Ishunina, B. Fisser and D.F. Swaab, Sex differences in androgen receptor immunoreactivity in basal forebrain nuclei of elderly and Alzheimer patients, Exp Neurol 176 (2002), 122-132.
48. J.S. Janowsky, B. Chavez and E. Orwoll, Sex steroids modify working memory, J Cogn Neurosci 12 (2000), 407-412.
49. J.S. Janowsky, S.K. Oviatt and E.S. Orwoll, Testosterone Influences Spatial Cognition in Older Men, Behav Neurosci 108 (1994), 325-332.
50. D.F. Jarrard, H. Kinoshita, Y. Shi, C. Sandefur, D. Hoff, L.F. Meisner, C. Chang, J.G. Herman, W.B. Issacs and N. Hassif, Methylation of the androgen receptor promotor CpG island is associated with loss of androgen receptor expression in prostate cancer cells, Cancer Res 58 (1998), 5310-5314.
51. J. Kang, H.G. Lemaire, A. Unterbeck, J.M. Salbaum, C.L. Masters, K.H. Grzeschik, G. Multhaup, K. Beyreuther and B. Muller-Hill, The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor, Nature 325 (1987), 733-736.
52. J.M. Kaufman and A. Vermeulen, The decline of androgen levels in elderly men and its clinical and therapeutic implications, Endocr Rev 26 (2005), 833-876.
53. P. Kazemi-Esfarjani, M.A. Trifiro and L. Pinsky, Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies, Hum Mol Genet 4 (1995), 523-527.
54. J.W. Kemnitz, E.B. Roecker, A.L. Haffa, J. Pinheiro, I. Kurzman, J.J. Ramsey and E.G. MacEwan, Serum dehydroepiandrosterone sulfate concentrations across the life span of laboratory-housed rhesus monkeys, Med Primatol 29 (2000), 330-337.
55. A.M. Kenny, S. Bellantonio, C.A. Gruman, R.D. Acosta and K.M. Prestwood, Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable tetosterone levels, J Gerontol A Biol Sci Med Sci 57 (2002), M321-M325.
56. A.M. Kenny, G. Fabregas, C.W. Song, B. Biskup and S. Bellantonio, Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss, J Gerontol A Biol Sci Med Sci 59 (2004), 75-78.
57. J.E. Kerr, R.J. Allore, S.G. Beck and R.J. Handa, Distribution and hormonal regulation of androgen receptor (AR) and AR mesenger ribonucleic acid in the rat hippocampus, Endocrinology 136 (1995), 3213-3221.
58. V. G. Kimonides, N.H. Khatibi, C.N. Svendsen, M.V. Sofroniew and J. Herbert, Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity, Proc Natl Acad Sci 95 (1998), 1852-1857.
59. D. Kimura, REVIEW. Sex hormones influence human cognitive pattern, Neuro Endocrinol Lett 23 (2002), 67-77.
60. H. Kinoshita, Y. Shi, C. Sandefur, L.F. Meisner, C. Chang, A. Choon, C.R. Reznikoff, G.S. Bova, A. Friedl and D.F. Jarrard, Methylation of the androgen receptor minimal promotor silences transcription in human prostate cancer, Cancer Res 60 (2000), 3623-3630.
61. S. Kousteni, T. Bellido, L.I. Plotkin, C.A. O'Brien, D.L. Bodenner, L. Han, K. Han, G.B. DiGregorio, J.A. Katzenellenbogen, B.S. Katzenellenbogen, P.K. Roberson, R.S. Weinstein, R.L. Jilka and S.C. Manolagas, Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity, Cell 104 (2001), 719-730.
62. K. Krithivas, S.M. Yurgalevitch, B.A. Mohr, C.J. Wilcox, S.J. Batter, M. Brown, C. Longcope, J.B. McKinlay and P.W. Kantoff, Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men, J Endocrinol 162 (1999) 137-142.
63. N. Kumar, A. Crozat, F. Li, J.F. Caterall, C.W. Bardin and K. Sundaram, 7 alpha-methyl-19-nortestosterone, a synthetic androgen with high potency: structure-activity comparisons with other androgens, J Steroid Biochem Mol Biol 71 (1999), 213-222.
64. R.C. Kumar and M.K. Thakur, Androgen receptor mRNA is inversely regulated by testosterone and estradiol in adult mouse brain, Neurobiol Aging 25 (2004), 925-933.
65. A.R. La Spada, E.M. Wilson, D.B. Lubahn, A.E. Harding and K.H. Fischbeck, Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy, Nature 352 (1991), 77-79.
66. L.J. Launer, K. Andersen, M.E. Dewey, L. Letenneur, A. Ott, L.A. Amaducci, C. Brayne, J.R. Copeland, J.F. Dartigues, P. Kragh-Sorensen, A. Lobo, J.M. Martinez-Lage, T. Stijnen and A. Hofman. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 52 (1999) 78-84.
67. B.Z. Leder, J.L. Rohrer, S.D. Rubin, J. Gallo and C. Longcope, Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels, J Clin Endocrinol Metab 89 (2004), 1174-1180.
68. D.J. Lehmann, E. Hogervorst, D.R. Warden and A.D. Smith, The androgen receptor CAG repeat and serum testosterone in the risk of Alzheimer's disease in men, J Neurol Neurosurg Psychiatry 75 (2004), 163-171.
69. C.N. Lessov-Schlaggar, T. Reed, G.E. Swan, R.E. Krasnow, C. DeCarli, R. Marcus, L. Holloway, P.A. Wolf and D. Carmelli, Association of sex steroid hormones with brain morphology and cognition in healthy elderly men, Neurology 65 (2005), 1591-1596.
70. L. Letenneur, L.J. Launer, K. Andersen, M.E. Dewey, A. Ott, J.R. Copeland, J.F. Dartigues, P. Kragh-Sorensen, M. Baldereschi, C. Brayne, A. Lobo, J.M. Martinez-Lage, T. Stijnen and A. Hofman, Education and the risk for Alzheimer's disease: sex makes a difference. EURODEM pooled analyses. EURODEM Incidence Research Group, Am J Epidemiol 151 (2000), 1064-1071.
71. J. Lewis, D.W. Dickson, W.L. Lin, L. Chisholm, A. Corral, G. Jones, S.H. Yen N. Sahara, L. Skipper, D. Yager, C. Eckman, J. Hardy, M. Hutton and E. McGowan, Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP, Science 293 (2001), 1487-1491.
72. M.J. Linja and T. Visakorpi, Alterations of androgen receptor in prostate cancer, J Steroid Biochem Mol Biol 92 (2004), 255-264.
73. P.H. Lu, D.A. Masterman, R. Mulnard, C. Cotman, B. Miller, K. Yaffe, E. Reback, V. Porter, R. Swedloff and J.L. Cummings, Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men, Arch Neurol 63 (2006), 177-185.
74. Y.H. Lue, A.P. Hikim, R.S. Swerdloff, P. Im, K.S. Taing, T. Bui, A. Leung and C. Wang, Single exposure to heat induces stage-specific germ cell apoptosis in rats: role of intratesticular testosterone on stage specificity, Endocrinology 140 (1999), 1709-1717.
75. L.P. Ly, M. Jimenez, T.N. Zhuang, D.S. Celermajer, A.J. Conway and D.J. Handelsman, A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency, J Clin Endocrinol Metab 86 (2001), 4078-4088.
76. J.R. Lynch, W. Tang, H. Wang, M.P. Vitek, E.R. Bennett, P.M. Sullivan, D.S. Warner and D.T. Laskowitz, APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response, J Biol Chem 278 (2003), 48529-48533.
77. R. Maayan, D. Touati-Werner, E. Ram, M. Galdor and A. Weizman, Is brain dehydroepiandrosterone synthesis modulated by free radicals in mice? Neurosci Lett 377 (2005), 130-135.
78. J. Magrane, R.C. Smith, K. Walsh and H.W. Querfurth, Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons, J Neurosci 24 (2004), 1700-1706.
79. M. Markowski, M. Ungeheuer, D. Bitran and C. Locurto, Memory-enhancing effects of DHEAS in aged mice on a win-shift water escape task, Physiol Behav 72 (2001), 521-525.
80. R.N. Martins, P.J. Robinson, J.O. Chleboun, K. Beyreuther and C.L. Masters, The molecular pathology of amyloid deposition in Alzheimer's disease, Mol Neurobiol 5 (1991), 389-398.
81. C.L. Masters, G. Simms, N.A. Weinman, G. Multhaup, B.L. McDonald and K. Beyreuther, Amyloid plaque core protein in Alzheimer disease and Down syndrome, Proc Natl Acad Sci 82 (1985), 4245-4249.
82. E.A. Milward, R. Papadopoulos, S.J. Fuller, R.D. Moir, D. Small, K. Beyreuther and C.L. Masters, The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth, Neuron 9 (1992), 129-137.
83. S.D. Moffat, Effects of testosterone on cognitive and brain aging in elderly men, Ann NY Acad Sci 1055 (2005), 80-92.
84. S. D. Moffat and E. Hampson, A curvilinear relationship between testosterone and spatial cognition in humans: Possible influence of hand preference, Psychoneuroendocrinology 21 (1996), 323-337.
85. S.D. Moffat, A.B. Zonderman and S.M. Harman, The relationship between longitudinal declines in dehydroepiandrosterone sulfate concentrations and cognitive performance in older men, Arch Intern Med 160 (2000), 2193-2198.
86. S.D. Moffat, A.B. Zonderman, E.J. Metter, C. Kawas, M.R. Blackman, S.M. Harman and S.M. Resnick, Free testosterone and risk for Alzheimer disease in older men, Neurology 62 (2004), 188-193.
87. A.D. Mooradian, J.E. Morley and S.G. Korenman, Biological actions of androgens, Endocr Rev 8 (1987), 1-28.
88. M.F. Morrison, E. Redei, T. TenHave, P. Parmelee, A.A. Boyce, P.S. Sinha and I.E. Katz, Dehydroepiandrosterone sulfate and psychiatric measures in a frail, elderly residential care population. Biol Psychiatry 47 (2000), 144-150.
89. T.V. Nguyen, M. Yao and C.J. Pike, Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection, J Neurochem 94 (2004), 1639-1651.
90. D.B. O'Connor, J. Archer, W.M. Hair and F.C. Wu, Activational effects of testosterone on cognitive function in men, Neuropsychologia 39 (2001), 1385-1394.
91. A. Ohta, I. Akiguchi, N. Seriu, K. Ohnishi K, H. Yagi, K. Higuchi and M. Hosokawa, Deterioration in learning and memory of inferential tasks for evaluation of transitivity and symmetry in aged SAMP8 mice, Hippocampus 12 (2002), 803-810.
92. K.N. Pandey, P.M. Oliver, N. Maeda and O. Smithies, Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A-gene-knockout and gene-duplicated mutant mouse models, Endocrinology 140 (1999), 5112-5119.
93. S.C. Papasozomenos. The heat shock-induced hyperphosphorylation of tau is estrogen-independent and prevented by androgens: implication for Alzheimer disease, Proc Natl Acad Sci 94 (1997), 6612-6617.
94. V.K. Patchev, J. Schroeder, F. Goetz, W. Rohde and A.V. Patchev, Neurotropic action of androgens: principles, mechanisms and novel targets, Exp Gerontol 39 (2004), 1651-1660.
95. S.S. Petanceska, V. Nagy, D. Frail and S. Gandy, Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain, Exp Gerontol 35 (2000), 1317-1325.
96. R.C. Petersen, R. Doody, A. Kurz, R.C. Mohs, J.C. Morris, P.V. Rabins, K. Ritchie, M. Rossor, L. Thal and B. Winblad, Current concepts in mild cognitive impairment, Arch Neurol 58 (2001), 985-992.
97. C.J. Pike, E.R. Rosario and T.V.V. Nguyen, Androgens, aging and Alzheimer's disease, Endocrine 29 (2006), 233-241.
98. C. Qiu, M. Kivipelto, H. Aguero-Torres, B. Winblad and L. Fratiglioni, Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex, J Neurol Neurosurg Psychiatry 75 (2004), 828-833.
99. J. Raber, Androgens, apolipoprotein E and Alzheimer's disease, Sci Aging Knowledge Environ 11 (2004), re2.
100. J. Raber, G. Bongers, A. Le Fevour, M. Buttini and L. Mucke, Androgens protect against apolipoprotein E4-induced cognitive deficits, J Neurosci 22 (2002), 5204-5209.
101. M. Racchi, C. Balduzzi and E. Corsini, Dehydroepiandrosterone (DHEA) and the aging brain: flipping a coin in the "fountain of youth", CNS Drug Rev 9 (2003), 21-40.
102. M. Ramsden, A.C. Nyborg, M.P. Murphy, L. Chang, F.Z. Stanczyk, T.E. Golde and C.J. Pike, Androgens modulate beta-amyloid levels in male rat brain, J Neurochem 87 (2003), 1052-1055.
103. D.S. Reddy and S.K. Kulkarni, Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment, Brain Res 799 (1998), 215-229.
104. S.L. Ripp, J.L. Fitzpatrick, J.M. Peters and R.A. Prough, Induction of CYP3A expression by dehydroepiandrosterone: involvement of the pregnane X receptor, Drug Metab Dispos 30 (2002), 570-575.
105. E.R. Rosario, L. Chang, F.Z. Stanczyk and C.J. Pike, Age-related testosterone depletion and the development of Alzheimer disease, JAMA 292 (2004), 1431-1432.
106. D.R. Rubinow and P.J. Schmidt, Androgen, brain, and behavior, Am J Psychiatry 153 (1996), 974-984.
107. A. Ruitenberg, A. Ott, J.C. van Swieten, A. Hofman and M.M. Breteler, Incidence of dementia: does gender make a difference? Neurobiol Aging 22 (2001), 575-580.
108. B.S. Schoenberg, E. Kohmen and H. Okazaki, Alzheimer's disease and other dementing illnesses in a defined United States population: incidence rates and clinical features, Ann Neurol 22 (1987), 724-729.
109. S. Seshadri, P.A. Wolf, A. Beiser, R. Au, K. McNulty, R. White and R.B. D'Agostino, Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study, Neurology 49 (1997), 1498-1504.
110. S. Shen, D.M. Cooley, L.T. Glickman, N. Glickman and D.J. Waters, Reduction in DNA damage in brain and peripheral blood lymphocytes of elderly dogs after treatment with dehydroepiandrosterone (DHEA), Mutat Res 480 (2001), 153-162.
111. R.A. Short, R.L. Bowen, P.C. O'Brien and N.R. Graff-Radford, Elevated gonadotropin levels in patients with Alzheimer's disease, Mayo Clin Proc 76 (2001), 906-909.
112. R. Sih, J.E. Morley, F.E. Kaiser, H.M. Perry, P. Patrick and C. Ross, Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial, J Clin Endocrinol Metab 82 (1997), 1661-1667.
113. R.B. Simerly, C. Chang, M. Muramatsu and L.W. Swanson, Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study, J Comp Neurol 294 (1990), 76-95.
114. D.H. Small, H.L. Clarris, T.G. Williamson, G. Reed, B. Key, S.S. Mok, K. Beyreuther, C.L. Masters and V. Nurcombe, Neurite outgrowth regulating functions of the amyloid protein precursor of Alzheimer's disease, J Alzheimers Dis 1 (1999), 275-285.
115. D.B. Solit, H.I. Scher and N. Rosen, Hsp90 as a therapeutic target in prostate cancer, Semin Oncol 30 (2003), 709-716.
116. H. Sternbach, Age-associated testosterone decline in men: clinical issues for psychiatry, Am J Psychiatry 155 (1998), 1310-1318.
117. W.J. Strittmatter, A.M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G.S. Salvesen and A.D. Roses, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc Natl Acad Sci 90 (1993), 1977-1981.
118. R.S. Tan, Memory loss as a reported symptom of andropause, Arch Androl 47 (2001), 185-189.
119. R.S. Tan and S.J. Pu, The andropause and memory loss: is there a link between androgen decline and dementia in the aging male? Asian J Androl 3 (2001), 169-174.
120. M.K. Thakur, A. Asaithambi and S. Mukherjee, Synthesis and phosphorylation of androgen receptor of the mouse brain cortex and their regulation by sex steroids during aging, Mol Cell Biochem 203 (2000), 95-101.
121. P. Tirassa, I. Thiblin, G. Agren, E. Vigneti, L. Aloe and C. Stenfors, High-dose anabolic androgenic steroids modulate concentrations of nerve growth factor and expression of its lowaffinity receptor (p75-NGFr) in male rat brain, J Neurosci Res 47 (1997), 198-207.
122. H. Tohgi, K. Utsugisawa, M. Yamagata and M. Yoshimura, Effects of age on messenger RNA expression of glucorticoid, thyroid hormone, androgen, and estrogen receptors in postmortem human hippocampus, Brain Res 700 (1995), 245-253.
123. V. Veereshwarayya, P. Kumar, K.M. Rosen, R. Mestril and H.W. Querfurth, Differential effects of mitochondrial heat shock protein 60 and related molecular chaperones to prevent intracellular beta-amyloid-induced inhibition of complex IV and limit apoptosis, J Biol Chem 281 (2006), 29468-29478.
124. A. Vermeulen and J.M. Kaufman, Diagnosis of hypogonadism in the aging male, Aging Male 3 (2002), 170-176.
125. L.G. Wang, X.M. Liu, W. Kreis and D.R. Budman, Phosphorylation/ dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity, Biochem Biophys Res Commun 259 (1999), 21-28.
126. S.J. Webb, T.E. Geoghegan, R.A. Prough and K.K.M. Miller, The biological actions of dehydroepiandrosterone involves multiple receptors, Drug Metab Rev 38 (2006), 89-116.
127. K.M. Webber, D.M. Stocco, G. Casadesus, R.L. Bowen, C.S. Atwood, L.A. Previll, P.L. Harris, X. Zhu, G. Perry and M.A. Smith, Steroidogenic acute regulatory protein (StAR): evidence of gonadotropin-induced steroidogenesis in Alzheimer disease, Mol Neurodegener 1 (2006), 14.
128. S.C. Weninger and B.A. Yankner, Inflammation and Alzheimer disease: The good, the bad and the ugly, Nature Med 7 (2001), 527-528.
129. O.T. Wolf and C. Kirschbaum. Actions of dehydroepiandrosterone and its sulfate in the central nervous system: effect on cognition and emotion in animals and humans, Brain Res Brain Rev 30 (1999), 265-288.
130. T. Wyss-Coray, J.D. Loike, T.C. Brionne, E. Lu, R. Anankov, F. Yan, S.C. Silverstein and J. Husemann, Adult mouse astrocytes degrade amyloid-β in vitro and in situ, Nat Med 9 (2003), 453-457.
131. B.B. Yeap and J.A. Wilce, The androgen receptor mRNA, Bioessays 26 (2004), 672-682.
132. A. Yoshizawa and D.R. Clemmons, Testosterone and insulin-like growth factor (IGF) I interact in controlling IGF-binding protein production in androgen-responsive foreskin fibroblasts, J Clin Endocrinol Metab 85 (2000), 1627-1633.
133. M.P. Zeegers, L.A. Kiemeney, A.M. Nieder and H. Ostrer, How strong is the association between CAG and GGN repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiol Biomarkers Prev 13 (2004), 1765-1771.
134. Y. Zhang, N. Champagne, L.K. Beitel, C.G. Goodyer, M. Trifiro and A. LeBlanc, Estrogen and androgen protection of human neurons against intracellular amyloid beta 1-42 toxicity through heat shock protein 70, J Neurosci 24 (2004), 5315-5321.
135. O. Zinder and D.E. Dar, Neuroactive steroids: their mechanism of action and their function in the stress response, Acta Physiol Scand 167 (1999), 181-188.
136. M. Zitzmann, M. Weckesser, O. Schober and E. Nieschlag, Changes in cerebral glucose metabolism and visuospatial capacity in hypogonadal males under testosterone substitution therapy, Exp Clin Endocrinol Diabetes 109 (2001), 302-304.
137. I.H. Zwain and S.S. Yen, Dehydroepiandrosterone: biosynthesis and metabolism in the brain, Endocrinology 140 (1999), 880-887.